Anabolic-androgenic steroids for alcoholic liver disease: A Cochrane review

American Journal of Gastroenterology

Volumn 97, Issue 7, 2002, Pages 1674-1681

  Rambaldi, Andrea ^a,b   Iaquinto, Gaetano ^b   Gluud, Christian ^a  

^a Mental Health Services CPH   (Denmark)

^b S G MOSCATI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; METENOLONE ENANTATE; OXANDROLONE; PLACEBO; TESTOSTERONE; TESTOSTERONE PROPIONATE;

ALCOHOL LIVER DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBASE; FEMALE; HEART INFARCTION; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER VEIN THROMBOSIS; MAJOR CLINICAL STUDY; MALE; MEDLINE; META ANALYSIS; MORTALITY; NAUSEA; POLYCYTHEMIA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0036311104     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04182-5     Document Type: Article

References (74)

1. Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men
2. Alcohol, levercirrhose, en stoornissen in het metabolisme van de geslachtshormonen. (Alcohol, liver cirrhosis, and disorders in sex hormone metabolism.)
3. Hypothalamic-pituitarygonadal function in relation to liver function in men with alcoholic cirrhosis
4. Serum testosterone concentrations in men with alcoholic liver cirrhosis: Background for variation
5. The influence of ethanol and liver disease on sex hormones and hepatic oestrogen receptors in women
6. Diagnosis and treatment of alcoholic liver disease in Europe
7. Anabolic-androgenic steroid treatment of liver diseases
8. Anabolic-androgenic steroids for alcoholic liver disease
9. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
10. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses
11. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses
12. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function
13. Testosterone treatment of men with alcoholic cirrhosis: A double-blind study
14. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone
15. Risk factors and therapy in alcoholic hepatitis (AH)
16. Treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone: A randomized controlled trial. I. Short-term effects on liver function
17. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition
18. Treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone: A randomized controlled trial. II. Effects on nitrogen metabolism
19. The effect of oral testosterone on serum TBG levels in alcoholic cirrhotic men
20. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis
21. Effect of testosterone treatment in men with alcoholic cirrhosis
22. Liver haemodynamics and function in alcoholic cirrhosis. Relation to testosterone treatment and ethanol consumption
23. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men
24. Serum concentrations in men with alcoholic cirrhosis: Background for variation
25. The nonefficacy of short-term anabolic steroid therapy in alcoholic liver disease
26. Testosterone in the management of cirrhosis of the liver-a controlled study
27. Prednisolone and testosterone propionate in cirrhosis of the liver. A controlled trial
28. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veteran Affairs Cooperative Study
29. Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver
30. Anabolic steroid therapy as an adjunct to diet in alcoholic hepatic steatosis
31. Therapy with oxandrolone (OX) and a high calorie supplement improves nutritional status in dempensated alcoholic hepatitis (AH) with moderate proteine calorie malnutrition (PCM)
32. Protein energy malnutrition in severe alcoholic hepatitis: Diagnosis and response to treatment
33. Relationship of protein calorie malnutrition to alcoholic liver disease: A reexamination of data from two Veterans Administration cooperative studies
34. Improve cognitive function as the result of nutrition therapy for patients with alcoholic hepatitis
35. Does high protein intake increase the risk of hepatic encephalopathy (HE) in patients with alcoholic hepatitis (AH)?
36. Nutritional therapy for alcoholic hepatitis
37. Kontrollierte studie zur therapeutischen wirkung von B vitaminen und einem anabolen steroid bei chronischer hepatitis
38. Die beeinflussung des schweren leberparenchymschadens unter zufuhr hochdosierter androgenderivate und von corticosteroiden
39. Mesterolone in steatosis and cirrhosis of the liver
40. Langzeitbehandlung chronischer lebererkrankungen mit prednison und methandrostenolon
41. Severe alcoholic hepatitis improved by combined treatment with prednisolone, testosterone and an amino acid supplement
42. Treatment of ascitic atrophic cirrhosis of the liver with high dosages of testosterone propionate
43. Short-term parenteral and peroral testosterone administration in men with alcoholic cirrhosis
44. Anabolic steroid effect on hepatic protein synthesis in patients with liver cirrhosis
45. Testosterone propionate in cirrhosis of the liver
46. Protein anabolism and fatty liver of the alcoholic
47. Effect of testosterone application on hormone concentrations of androgens and estrogens in male patients with cirrhosis of the liver
48. Die wirkung eines anabol wirkenden steroids (metenolononanthat) auf den intra-und extravasalen albuminpool bei leberzirrhose
49. Fatty liver: A study of 270 patients with biopsy proven fatty liver and a review of the literature
50. Langzeittherapie der leberzirrhose mit anabolen steroiden
51. Protein metabolism, excretion, and detoxication functions of the liver after long-term treatment of liver cirrhosis with an anabolic substance
52. The effect of administration of testosterone propionate on excretion of water in patients with cirrhosis of the liver
53. Treatment of cirrhosis of the liver with testosterone propionate
54. Therapie chronischer lebererkrankungen mit dacomid
55. Protein clotting factor synthesis in liver disease
56. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial
57. Metabolic and nutritional interventions in the treatment of alcoholic hepatitis
58. Analysis and interpretation of treatment effects in subgroups of patients in randomised clinical trials
59. A consumer's guide to subgroup analyses
60. Subgroup analysis and other mis(uses) of baseline data in clinical trials
61. Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases
62. Anabolic/androgenic steroid abuse and thrombosis: Is there a connection?
63. What certainty can there be on how much treatment work? Empirical insight from recursive cumulative meta-analyses
64. Colchicine for alcoholic and nonalcoholic liver fibrosis and cirrhosis
65. Propylthiouracil for alcoholic liver disease
66. Glucocorticoids are inffective in alcoholic hepatitis: A meta-analysis adjusting for confounding variables
67. Alcoholic hepatitis: Nō glucocorticosteroids?
68. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicentre sequential trial
69. Milk thistle (Silybum marianum) for the therapy of liver disease
70. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: A randomised controlled trial
71. Beneficial effects of polyenylphosphatidylcholine (PPC) in alcoholic and non-alcoholic liver injury
72. S-Adenosyl-methionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial
73. S-Adenosyl-L-methionine for alcoholic liver diseases